Robert J Deluccia insider trades
Open-market stock purchases and sales by Robert J Deluccia, Director at Acurx Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 18, 2014.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -77%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 20, 2026 | ACXP Acurx Pharmaceuticals, Inc | Bought (not open market) | — |